SCHEMBL30619418

SCHEMBL30619418

C=Cc1nc(OC)ccc1OC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 2/20 0.36
ALDH1A1 P00352 4/20 0.36
NQO2 P16083 1/20 0.35
TRPA1 O75762 1/20 0.35
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
MITF O75030 1/20 0.35
POLB P06746 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
KMT2A Q03164 2/20 0.33
LMNA P02545 2/20 0.33
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33
HPGD P15428 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
NNMT P40261 1/20 0.33
TUBB4A P04350 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26612238 1.00 ERN1 (0.36) ERN1ALDH1A1NQO2TRPA1PPARG
SCHEMBL26144370 0.80 CYP1A2 (0.41) ERN1ALDH1A1POLBTDP1KMT2A
SCHEMBL4980644 0.80 ERN1 (0.46) ERN1ALDH1A1NQO2POLBTDP1
SCHEMBL18512260 0.78 ALDH1A1 (0.38) ALDH1A1NQO2TRPA1PPARGPPARD
SCHEMBL30660389 0.78 NNMT (0.36) ERN1ALDH1A1POLBTDP1KMT2A
SCHEMBL7971706 0.78 MCHR1 (0.49) ALDH1A1NQO2TRPA1PPARGPPARD
SCHEMBL14188933 0.77 TUBB1 (0.35) ERN1ALDH1A1NQO2POLBTDP1
SCHEMBL2278549 0.74 NQO1 (0.42) ALDH1A1MITFKMT2AKDM4EHPGD
SCHEMBL23971206 0.73 TDP1 (0.60) ALDH1A1POLBTDP1SMN1; SMN2KMT2A
SCHEMBL30410828 0.73 POLB (0.47) ALDH1A1POLBTDP1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025085701-A1 PYRIDINE DERIVATIVES FOR TREATING PSYCHIATRIC DISORDERS GILGAMESH PHARMACEUTICALS, INC. (US) 2025-04-24 WO disclosed
EP-4511029-A1 PYRIDINE DERIVATIVES FOR TREATING PSYCHIATRIC DISORDERS Gilgamesh Pharmaceuticals, Inc. (US) 2025-02-26 EP disclosed
CN-119522098-A Pyridine derivatives for the treatment of psychotic disorders 吉尔伽美什制药公司 2025-02-25 CN disclosed
WO-2023205116-A1 PYRIDINE DERIVATIVES FOR TREATING PSYCHIATRIC DISORDERS GILGAMESH PHARMACEUTICALS, INC. (US) 2023-10-26 WO disclosed